Skip to main content
Terug
Watch Compare

AVITA Medical, Inc.

Datakwaliteit: 100%
Ook genoteerd als AVHHL Nasdaq
RCEL
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 4,38
▲ € 0,28 (6,71%)
Marktkapitalisatie: 134,01 M
Prijs
€ 4,38
Marktkapitalisatie
134,01 M
Dagbereik
€ 4,10 — € 4,50
52-Weeksbereik
€ 3,22 — € 10,29
Volume
297.723
Openen € 4,13
50D / 200D Gem.
€ 4,36
0,45% above
50D / 200D Gem.
€ 4,49
2,55% below

Quick Summary

Belangrijkste Punten

Revenue grew 50,51% annually over 5 years — strong growth
Negative free cash flow of -32,20 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 39,06%
Capital efficient — spends only 1,40% of revenue on capex

Groei

Revenue Growth (5Y)
50,51%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)11,45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-67,85%
Op. Margin-59,40%

Veiligheid

Debt / Equity
N/A
Current Ratio0,67
Interest Coverage-8,50

Waardering

PE (TTM)
-2,76
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,8 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -67,9 -41,5
Rev Growth 5Y % 50,5 1,8
D/E — 0,3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,03% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11,45% Revenue Growth (3Y) 19,50%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 50,51% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 71,61 M Net Income (TTM) -48,59 M
ROE N/A ROA -79,74%
Gross Margin 82,13% Operating Margin -59,40%
Net Margin -67,85% Free Cash Flow (TTM) -32,20 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,67
Interest Coverage -8,50 Asset Turnover 1,18
Working Capital -20,46 M Tangible Book Value -11,87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,76 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24,03%
Market Cap 134,01 M Enterprise Value 118,59 M
Per Share
EPS (Diluted TTM) -1,74 Revenue / Share 2,34
FCF / Share -1,05 OCF / Share -1,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,40% FCF Conversion 66,27%
SBC-Adj. FCF -44,43 M Growth Momentum -39,06

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 71,61 M 64,25 M 50,14 M 34,42 M 13,96 M
Net Income -48,59 M -61,85 M -35,38 M -26,67 M -14,43 M
EPS (Diluted) -1,74 -2,39 1,40 1,07 0,58
Gross Profit 58,82 M 55,16 M 42,36 M 28,38 M 12,05 M
Operating Income -42,53 M -56,59 M -42,66 M -27,51 M -14,42 M
EBITDA — — — — —
R&D Expenses 20,84 M 20,36 M 20,82 M 13,86 M 7,59 M
SG&A Expenses — — — — —
D&A 2,35 M 1,13 M 632.000,0 568.000,0 330.000,0
Interest Expense 5,00 M 5,36 M 1,14 M 16.000,0 17.000,0
Income Tax 11.000,0 54.000,0 66.000,0 36.000,0 25.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 56,39 M 79,71 M 111,64 M 98,26 M 116,02 M
Total Liabilities 73,04 M 74,97 M 61,89 M 12,97 M 11,39 M
Shareholders' Equity -16,65 M 4,50 M 49,06 M 84,74 M 104,62 M
Total Debt 0,0 42,25 M 39,81 M — —
Cash & Equivalents 10,24 M 14,05 M 22,12 M 18,16 M 55,51 M
Current Assets 35,49 M 57,00 M 104,01 M 87,46 M 92,13 M
Current Liabilities 62,68 M 20,16 M 13,20 M 10,69 M 9,15 M